Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis

Vaccine

Volumn 34, Issue 5, 2016, Pages 656-662

  Mellata, Melha ^a,e   Mitchell, Natalie M ^a,b   Schödel, Florian ^c   Curtiss, Roy ^a,b,f   Pier, Gerald B ^d  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c Philimmune LLC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e IOWA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antibodies; Antigens; Challenge; E. coli; Sepsis; Vaccine

Indexed keywords

ECPA ANTIGEN; ECPD ANTIGEN; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IRON ANTIGEN; IUTA ANTIGEN; MONOMER; N ACETYLGLUCOSAMINE; RABBIT ANTISERUM; RECOMBINANT ANTIGEN; SIDEROPHORE; TETANUS TOXOID; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BETA GLUCAN; CELL SURFACE RECEPTOR; CHAPERONE; ECPA PROTEIN, E COLI; ECPD PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; FIMBRIA PROTEIN; IMMUNOGLOBULIN G; IRON PROTEIN, E COLI; POLY-N-ACETYL-1-6-GLUCOSAMINE; VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM PILUS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; DRUG MEGADOSE; ESCHERICHIA COLI INFECTION; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; IMMUNE RESPONSE; INFECTION PREVENTION; IRON TRANSPORT; LOW DRUG DOSE; MOUSE; MURINE MODEL; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; UROSEPSIS; ANIMAL; BLOOD; ESCHERICHIA COLI INFECTIONS; IMMUNOLOGY; RABBITS AND HARES; SEPSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BETA-GLUCANS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FEMALE; FIMBRIAE PROTEINS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; MOLECULAR CHAPERONES; RABBITS; RECEPTORS, CELL SURFACE; SEPSIS; VACCINES, CONJUGATE;

EID: 84953790738     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.014     Document Type: Article

References (43)

1. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2(2):123-140.
2. Mellata M. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis 2013, 10(11):916-932.
3. Artero A., Zaragoza R., Camarena J.J., Sancho S., Gonzalez R., Nogueira J.M. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care 2010, 25(2):276-281.
4. *. Crit Care Med 2012, 40(7):2016-2021.
5. Levy M.M., Dellinger R.P., Townsend S.R., Linde-Zwirble W.T., Marshall J.C., Bion J., et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensiv Care Med 2010, 36(2):222-231.
6. Gastmeier P., Schwab F., Meyer E., Geffers C. Excess mortality and prolongation of stay due to bloodstream infections caused by multiresistant pathogens in Germany. Dtsch Med Wochenschr 2012, 137(34-35):1689-1692.
7. Durant L., Metais A., Soulama-Mouze C., Genevard J.M., Nassif X., Escaich S. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 2007, 75(4):1916-1925.
8. Alteri C.J., Hagan E.C., Sivick K.E., Smith S.N., Mobley H.L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 2009, 5(9):e1000586.
9. Russo T.A., McFadden C.D., Carlino-MacDonald U.B., Beanan J.M., Olson R., Wilding G.E. The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 2003, 71(12):7164-7169.
10. Russo T.A., Carlino-MacDonald U. Extraintestinal pathogenic isolates of Escherichia coli do not possess active IgA1, IgA2, sIgA or IgG proteases. FEMS Immunol Med Microbiol 2008, 53(1):65-71.
11. Langermann S., Palaszynski S., Barnhart M., Auguste G., Pinkner J.S., Burlein J., et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997, 276(5312):607-611.
12. Roberts J.A., Kaack M.B., Baskin G., Chapman M.R., Hunstad D.A., Pinkner J.S., et al. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J Urol 2004, 171(4):1682-1685.
13. Mellata M., Touchman J.W., Curtiss R. Full sequence and comparative analysis of the plasmid pAPEC-1 of avian pathogenic E. coli chi7122 (O78:K80:H9). PLoS One 2009, 4(1):e4232.
14. Rendon M.A., Saldana Z., Erdem A.L., Monteiro-Neto V., Vazquez A., Kaper J.B., et al. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci U S A 2007, 104(25):10637-10642.
15. Lehti T.A., Bauchart P., Heikkinen J., Hacker J., Korhonen T.K., Dobrindt U., et al. Mat fimbriae promote biofilm formation by meningitis-associated Escherichia coli. Microbiology 2010, 156(Pt 8):2408-2417.
16. Lehti T.A., Heikkinen J., Korhonen T.K., Westerlund-Wikstrom B. The response regulator RcsB activates expression of Mat fimbriae in meningitic Escherichia coli. J Bacteriol 2012, 194(13):3475-3485.
17. Saldana Z., De la Cruz M.A., Carrillo-Casas E.M., Duran L., Zhang Y., Hernandez-Castro R., et al. Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium. PLoS One 2014, 9(7):e101200.
18. Stacy A.K., Mitchell N.M., Maddux J.T., De la Cruz M.A., Duran L., Giron J.A., et al. Evaluation of the prevalence and production of Escherichia coli common pilus among avian pathogenic E. coli and its role in virulence. PLoS One 2014, 9(1):e86565.
19. Gening M.L., Maira-Litran T., Kropec A., Skurnik D., Grout M., Tsvetkov Y.E., et al. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010, 78(2):764-772.
20. Welch R.A., Burland V., Plunkett G., Redford P., Roesch P., Rasko D., et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 2002, 99(26):17020-17024.
21. Bertani G. Lysogeny at mid-twentieth century: P1, P2, and other experimental systems. J Bacteriol 2004, 186(3):595-600.
22. Wang X., Preston J.F., Romeo T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 2004, 186(9):2724-2734.
23. Juarez-Rodriguez M.D., Arteaga-Cortes L.T., Kader R., Curtiss R., Clark-Curtiss J.E. Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system. Infect Immun 2012, 80(2):798-814.
24. Juarez-Rodriguez M.D., Yang J., Kader R., Alamuri P., Curtiss R., Clark-Curtiss J.E. Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis. Infect Immun 2012, 80(2):815-831.
25. Wieser A., Romann E., Magistro G., Hoffmann C., Norenberg D., Weinert K., et al. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect Immun 2010, 78(8):3432-3442.
26. Mellata M., Ameiss K., Mo H., Curtiss R. Characterization of the contribution to virulence of three large plasmids of avian pathogenic Escherichia coli chi7122 (O78:K80:H9). Infect Immun 2010, 78(4):1528-1541.
27. Moriel D.G., Bertoldi I., Spagnuolo A., Marchi S., Rosini R., Nesta B., et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci U S A 2010, 107(20):9072-9077.
28. Chhibber S., Bajaj J. Polysaccharide-iron-regulated cell-surface protein conjugate vaccine-its role in protection against Klebsiella pneumoniae-induced lobar pneumonia. Vaccine 1995, 13(2):179-184.
29. Bolin C.A., Jensen A.E. Passive immunization with antibodies against iron-regulated outer membrane proteins protects turkeys from Escherichia coli septicemia. Infect Immun 1987, 55(5):1239-1242.
30. Garenaux A., Caza M., Dozois C.M. The Ins and outs of siderophore mediated iron uptake by extra-intestinal pathogenic Escherichia coli. Vet Microbiol 2011, 153(1-2):89-98.
31. Garnett J.A., Martinez-Santos V.I., Saldana Z., Pape T., Hawthorne W., Chan J., et al. Structural insights into the biogenesis and biofilm formation by the Escherichia coli common pilus. Proc Natl Acad Sci U S A 2012, 109(10):3950-3955.
32. Bouchet A., Valvano M.A., Dho-Moulin M., Le Roy D., Andremont A. Immunological variants of the aerobactin-cloacin DF13 outer membrane protein receptor IutA among enteric bacteria. Infect Immun 1994, 62(7):3017-3021.
33. Esposito A.L., Gleckman R.A., Cram S., Crowley M., McCabe F., Drapkin M.S. Community-acquired bacteremia in the elderly: analysis of one hundred consecutive episodes. J Am Geriatr Soc 1980, 28:315-319.
34. McCue J.D. Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology, and mortality. J Am Geriatr Soc 1987, 35:213-218.
35. Jackson L.A., Benson P., Neuzil K.M., Grandjean M., Marino J.L. Burden of community-onset Escherichia coli bacteremia in seniors. J Infect Dis 2005, 191:1523-1529.
36. Melzer M., Welch C. Is Escherichia coli bacteraemia preventable?. Lancet Infect Dis 2012, 12(2):103-104. [United States].
37. Cywes-Bentley C., Skurnik D., Zaidi T., Roux D., Deoliveira R.B., Garrett W.S., et al. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A 2013, 110(24):E2209-E2218.
38. Subashchandrabose S., Smith S.N., Spurbeck R.R., Kole M.M., Mobley H.L. Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PloS Pathog 2013, 9(12):e1003788.
39. Wright K.J., Seed P.C., Hultgren S.J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 2005, 73(11):7657-7668.
40. Hagan E.C., Mobley H.L. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 2007, 75(8):3941-3949.
41. Johnson T.J., Siek K.E., Johnson S.J., Nolan L.K. DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strains. J Bacteriol 2006, 188(2):745-758.
42. Koga V.L., Tomazetto G., Cyoia P.S., Neves M.S., Vidotto M.C., Nakazato G., et al. Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. Biomed Res Int 2014, 2014. [465054].
43. Lehti T.A., Bauchart P., Kukkonen M., Dobrindt U., Korhonen T.K., Westerlund-Wikstrom B. Phylogenetic group-associated differences in regulation of the common colonization factor Mat fimbria in Escherichia coli. Mol Microbiol 2013, 87(6):1200-1222.